PUBLISHED DATE : Apr 2022 | Pages : 335
Fill out your details & get your free sample
Global Remote Patient Monitoring Market Size, Share, Trends, Analysis by
Industry Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share, & Forecast 2022-2027
335 Pages
93 Tables
149 Charts
5 Regions
18 Countries
47 Companies
5 Market Segment
| Report Attribute | Details |
|---|---|
| MARKET SIZE (2021) | USD 30.56 BILLION |
| MARKET SIZE (2027) | USD 62 BILLION |
| CAGR | 12.5% (2022-2027) |
| BASE YEAR | 2021 |
| FORECAST YEAR | 2022-2027 |
| LARGEST MARKET | North America |
| GEOGRAPHIC ANALYSIS | North America (US, Canada), Europe (U.K, Germany, Italy, France, Spain), APAC (China, Japan, India, South Korea, Australia), Latin America (Brazil, Mexico, Argentina) & MEA (Turkey, Saudi Arabia, South Africa) |
The global remote patient monitoring market was valued at USD 30 billion in 2021 and is expected to reach USD 62 billion, growing at a CAGR of 12.5% during the forecast period. According to the Arizton market research report, the market is expected to grow due to an increase in demand for remote patient monitoring systems and devices due to the COVID-19 pandemic.
The global remote patient monitoring market is expected to grow at a remarkable growth due to technological improvements, a greater focus on public health, more consumer awareness of the benefits of RPM, and lower prices. Moreover, several traditional medical devices manufacturers are gradually expanding their product portfolios and focusing on launching remote patient monitoring devices integrated with advanced technologies, such as the Internet of Things.
Remote patient monitoring is achieved by using digital technologies to monitor and capture medical health-related data from patients and electronically transmit the information to healthcare providers for assessment, and, when necessary, recommendations and instructions are provided. RPM reduces the number of readmissions in the medical requirement, hospitalizations, and duration of stay in the hospital, which leads to improved quality of life and contain costs.
Chronic diseases and other related disorders accounted for nearly three-quarters of all deaths worldwide in 2020. According to the World Health Organization, 71% of deaths due to ischemic heart disease (IHD), 75% of deaths due to stroke, and 70% of deaths due to diabetes occur in developing countries. In developing nations, the number of persons living with diabetes is expected to be more than double by 2025, from 84 million in 1995 to 228 million.
According to the Centers for Disease Control and Prevention, six out of ten adults in the US suffer from a chronic illness. Chronic diseases are expected to afflict 164 million people in the US by 2025, accounting for over half that is 49% of the population. Multidisciplinary teams in primary care and public health are superior at preventing and managing chronic disease. According to Project HOPE: The People-to-People Health Foundation, Inc., the number of persons with persistent mental disorders is expected to rise from 30 million to 47 million by 2023. Almost every prevalent chronic illness is expected to see similar rates.
Rising Demand due to COVID-19 Pandemic
The need for remote patient monitoring devices has been steadily increasing as the number of COVID-19 patients in hospitals and medical facilities worldwide has increased. The demand for remote patient monitoring equipment has increased dramatically, particularly among patients with chronic conditions. The increase in awareness regarding COVID-19 and increasing worry to get infected because of a hospital visit is driving the global remote patient monitoring market growth.
The Devices and Software segment accounted for the largest share in the global remote patient monitoring market. With the emergence of connected cardiac implants, cardiology was one of the first specialties to incorporate RPM. Cardiology practices are now particularly well-positioned to gain the short and long-term benefits associated with the progression of RPM services, technology, and regulation. The cardiac monitoring market is further propelled by innovative product characteristics, as well as the increased need and demand for virtual care solutions in the COVID-19 era. The cardiac monitor segment accounted for the maximum share in the remote patient monitoring market. For instance, according to CDC, 30.3 million US adults were identified with heart disorders in 2018. Thus, the high prevalence of cardiac disorder is expected to drive the segment.
Despite RPM's early popularity, some people are still unaware of the concept. RPM is a covered service that uses digital technologies and electronic monitoring to encourage patients to take a more active role in their health while also allowing practitioners to collect crucial patient data in between in-office appointments. RPM has various important applications in cardiology, including hypertension management, medication management, and weight for congestive heart failure patients.
The application of RPM devices is more prevalent in cardiology treatment as compared to pulmonology and endocrinology. The cardiology RPM programs enable cardiologists to streamline treatment and enhance their time management, which are two of the most significant benefits identified by cardiologists. Cardiologists can support a large patient base while lowering stress associated with burnout by tracking crucial patient data more easily and minimizing the frequency of in-office visits for some patients. RPM also improves the chances of detecting and resolving an impending health crisis while also giving practitioners greater insight into the patient's lifestyle and triggers, allowing them to make informed treatment modifications.
Hospitals & specialty clinics contribute maximum revenue share to the market as RPMs are primarily used in hospitals & specialty clinics. The use of RPM and a centralized virtual care team at hospitals & clinics has significantly reduced the hospital readmission rate and has lowered overall acute care resource utilization among acutely ill patients. Continuous remote monitoring of hospitalized patients treated in general medical settings not only improves outcomes but also increases accuracy and reduces the burden of obtaining and documenting patients' vital signs on overworked and under-resourced staff by automating a task that is to be performed several times per day for each patient when integrated into the electronic health record (EHR). All these factors propel the adoption of RPM devices and software in hospitals and clinics, thus further boosting the market growth.
North America accounted for a significant 40% of the global market for remote patient monitoring market share in 2021. The presence of substantial competitors and their growth strategies are the main factors driving the North American market. The industry is driven by rising healthcare spending and increased awareness about the benefits of sickness prevention. An increase in heart ailments, sedentary lifestyles, and the deployment of e-health in some rural areas of North America is expected to drive the market growth. The government's involvement in introducing telehealth technology to rural areas and the existence of significant corporations in the area all contribute to the market expansion.
With many top companies in the global market and several small players in regional markets, the global remote patient monitoring market is somewhat fragmented. The major competitors in the market are focusing their efforts on reducing the size of the remote patient monitoring market. These companies are also attempting to increase their market share by launching new goods and forming collaborations with other market participants. As a result, these factors are expected to propel the remote patient monitoring market growth.
Resideo Technologies, Medtronic, Philips Healthcare, and ResMed are among the leading companies for Devices and Software. Withings, MedM, iHealthUnifiedcare, and Qardio are among the top companies in the industry.
100Plus, A&D Medical, Abbott, Altumview Systems, Biotronik, Boston Scientific, Bardy Diagnostics, Cardiomo, Cardiologs, Dragerwerk AG, F. Hoffmann-La Roche Ltd, Fluxion Biosciences, GE Healthcare, GrandCare Systems, Masimo Corporation, Medopad, Nihon Kohden, Omron Healthcare, OSPLabs, Qualcomm Technologies, Senseonics, VitalConnect, are among the leading players.
Frequently Asked Questions
What is the size of the remote patient monitoring market?
The remote patient monitoring market was valued at USD 30.56 BN in 2021 and is expected to reach USD 61.78 BN by 2027.
What is the remote patient monitoring system market growth?
The remote patient monitoring market is expected to grow at a CAGR of 12.5% during 2021-2027.
Who are the leading players in the remote patient monitoring market?
Resideo Technologies, Medtronic, Philips Healthcare, and ResMed are among the leading companies in the global remote patient monitoring market for Devices and Software.
Which region will dominate the global remote patient monitoring market landscape?
North America remains the dominating market for remote patient monitoring due to the rising healthcare spending in the reason.
Mergers & Acquisitions are the key strategies that the companies are focusing on in the global remote patient monitoring devices industry.
The global remote patient monitoring market to grow at a CAGR of 12.5% during 2021-2027.
The report considers the present scenario of the remote patient monitoring market and its market dynamics for 2022−2027. It covers a detailed overview of several growth enablers, restraints, and trends. The study covers both the demand and supply sides of the industry. It also profiles and analyses leading companies and several other prominent companies operating in the industry.
Top Players
Other Prominent Players
Component:
Application
End-User
Geography
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET SEGMENTATION BY COMPONENT
4.3.2 MARKET SEGMENTATION BY APPLICATION
4.3.3 MARKET SEGMENTATION BY END-USER
4.3.4 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 MARKET AT A GLANCE
7 INTRODUCTION
7.1 OVERVIEW
7.1.1 COVID-19 IMPACT ON REMOTE PATIENT MONITORING MARKET
8 MARKET OPPORTUNITIES & TRENDS
8.1 INCREASING ROLE OF IOT IN REMOTE MONITORING & HEALTHCARE APPLICATIONS
8.2 PARADIGM SHIFT TOWARD HOME-BASED HEALTHCARE DEVICES
8.3 TELEMEDICINE USHERING NEW OPPORTUNITIES IN REMOTE MONITORING
9 MARKET GROWTH ENABLERS
9.1 AGING POPULATION VULNERABLE TO CHRONIC DISEASES
9.2 RISING WEARABLE MEDICAL TECHNOLOGY INNOVATIONS
9.3 GROWING USE OF RPM TO PROACTIVELY MONITOR & IMPROVE PATIENT ENGAGEMENT
9.4 INCREASED DEMAND FOR REMOTE MONITORING DUE TO COVID-19
10 MARKET GROWTH RESTRAINTS
10.1 LOW AWARENESS OF REMOTE MONITORING IN DEVELOPING COUNTRIES
10.2 LACK OF DATA ACCURACY
11 MARKET LANDSCAPE
11.1 MARKET OVERVIEW
11.2 MARKET SIZE & FORECAST
11.2.1 MARKET SHARE BY COMPONENT
11.2.2 MARKET SHARE BY DEVICES & SOFTWARE
11.2.3 MARKET SHARE BY APPLICATION
11.2.4 MARKET SHARE BY END-USER
11.2.5 MARKET BY GEOGRAPHY
11.3 FIVE FORCES ANALYSIS
11.3.1 THREAT OF NEW ENTRANTS
11.3.2 BARGAINING POWER OF SUPPLIERS
11.3.3 BARGAINING POWER OF BUYERS
11.3.4 THREAT OF SUBSTITUTES
11.3.5 COMPETITIVE RIVALRY
12 COMPONENT
12.1 MARKET SNAPSHOT & GROWTH ENGINE
13 DEVICES & SOFTWARE
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 CARDIAC MONITORING DEVICES
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.3.3 CARDIAC MONITORING DEVICES: MARKET BY GEOGRAPHY
13.4 ELECTROCARDIOGRAPHS (ECGS)
13.4.1 MARKET OVERVIEW
13.4.2 ELECTROCARDIOGRAM (ECG): MARKET SIZE & FORECAST
13.5 CARDIAC MONITORS
13.5.1 MARKET OVERVIEW
13.5.2 CARDIAC MONITORS: MARKET SIZE & FORECAST
13.6 BLOOD PRESSURE MONITORS
13.6.1 MARKET OVERVIEW
13.6.2 MARKET SIZE & FORECAST
13.7 OTHER CARDIAC MONITORING DEVICES
13.7.1 MARKET OVERVIEW
13.7.2 MARKET SIZE & FORECAST
13.8 RESPIRATORY MONITORING DEVICES
13.8.1 MARKET OVERVIEW
13.8.2 MARKET SIZE & FORECAST
13.8.3 RESPIRATORY MONITORING DEVICES: MARKET BY GEOGRAPHY
13.9 APNEA MONITORS
13.9.1 MARKET OVERVIEW
13.9.2 MARKET SIZE & FORECAST
13.10 PULSE OXIMETERS
13.10.1 MARKET OVERVIEW
13.10.2 MARKET SIZE & FORECAST
13.11 OTHER RESPIRATORY MONITORING DEVICES
13.11.1 MARKET OVERVIEW
13.11.2 MARKET SIZE & FORECAST
13.12 BLOOD GLUCOSE MONITORS
13.12.1 MARKET OVERVIEW
13.12.2 MARKET SIZE & FORECAST
13.12.3 BLOOD GLUCOSE MONITORS: MARKET BY GEOGRAPHY
13.13 FETAL & NEONATAL MONITORING DEVICES
13.13.1 MARKET OVERVIEW
13.13.2 MARKET SIZE & FORECAST
13.13.3 FETAL & NEONATAL MONITORING DEVICES: MARKET BY GEOGRAPHY
13.14 OTHER RPM DEVICES
13.14.1 MARKET OVERVIEW
13.14.2 MARKET SIZE & FORECAST
13.14.3 OTHER RPM DEVICES: MARKET BY GEOGRAPHY
13.15 SERVICES
13.15.1 MARKET OVERVIEW
13.15.2 MARKET SIZE & FORECAST
13.15.3 REMOTE PATIENT MONITORING SERVICES: MARKET BY GEOGRAPHY
14 APPLICATION
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 CARDIOLOGY
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.3.3 CARDIOLOGY REMOTE PATIENT MONITORING: MARKET BY GEOGRAPHY
14.4 PULMONOLOGY
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.4.3 PULMONOLOGY REMOTE PATIENT MONITORING: MARKET BY GEOGRAPHY
14.5 ENDOCRINOLOGY
14.5.1 MARKET OVERVIEW
14.5.2 MARKET SIZE & FORECAST
14.5.3 REMOTE ENDOCRINOLOGY PATIENT MONITORING: MARKET BY GEOGRAPHY
14.6 OTHERS
14.6.1 MARKET OVERVIEW
14.6.2 MARKET SIZE & FORECAST
14.6.3 OTHER: MARKET BY GEOGRAPHY
15 END-USER
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.3 HOSPITALS & SPECIALTY CLINICS
15.3.1 MARKET OVERVIEW
15.3.2 MARKET SIZE & FORECAST
15.3.3 HOSPITALS & SPECIALTY CLINICS: MARKET BY GEOGRAPHY
15.4 HOMECARE SETTINGS
15.4.1 MARKET OVERVIEW
15.4.2 MARKET SIZE & FORECAST
15.4.3 HOMECARE SETTINGS: MARKET BY GEOGRAPHY
15.5 AMBULATORY SURGICAL CENTERS
15.5.1 MARKET OVERVIEW
15.5.2 MARKET SIZE & FORECAST
15.5.3 AMBULATORY SURGICAL CENTERS: MARKET BY GEOGRAPHY
15.6 LONG-TERM & ACUTE CARE CENTERS
15.6.1 MARKET OVERVIEW
15.6.2 MARKET SIZE & FORECAST
15.6.3 LONG-TERM & ACUTE CARE CENTERS: MARKET BY GEOGRAPHY
15.7 OTHERS
15.7.1 MARKET OVERVIEW
15.7.2 MARKET SIZE & FORECAST
15.7.3 OTHERS: MARKET BY GEOGRAPHY
16 GEOGRAPHY
16.1 MARKET SNAPSHOT & GROWTH ENGINE
16.2 GEOGRAPHIC OVERVIEW
17 NORTH AMERICA
17.1 MARKET OVERVIEW
17.2 MARKET SIZE & FORECAST
17.3 NORTH AMERICA: COMPONENT SEGMENTATION (REVENUE)
17.4 NORTH AMERICA: APPLICATION SEGMENTATION (REVENUE)
17.5 NORTH AMERICA: END-USER SEGMENTATION (REVENUE)
17.6 NORTH AMERICA: KEY COUNTRIES
17.6.1 US: MARKET SIZE & FORECAST
17.6.2 CANADA: MARKET SIZE & FORECAST
18 EUROPE
18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.3 EUROPE: COMPONENT SEGMENTATION (REVENUE)
18.4 EUROPE: APPLICATION SEGMENTATION (REVENUE)
18.5 EUROPE: END-USER SEGMENTATION (REVENUE)
18.7 EUROPE: KEY COUNTRIES
18.7.1 GERMANY: MARKET SIZE & FORECAST
18.7.2 UK: MARKET SIZE & FORECAST
18.7.3 FRANCE: MARKET SIZE & FORECAST
18.7.4 SPAIN: MARKET SIZE & FORECAST
18.7.5 ITALY: MARKET SIZE & FORECAST
19 APAC
19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
19.3 APAC: COMPONENT SEGMENTATION (REVENUE)
19.4 APAC: APPLICATION SEGMENTATION (REVENUE)
19.5 APAC: END-USER SEGMENTATION (REVENUE)
19.6 APAC: KEY COUNTRIES
19.6.1 CHINA: MARKET SIZE & FORECAST
19.6.2 JAPAN: MARKET SIZE & FORECAST
19.6.3 INDIA: MARKET SIZE & FORECAST
19.6.4 AUSTRALIA: MARKET SIZE & FORECAST
19.6.5 SOUTH KOREA: MARKET SIZE & FORECAST
20 LATIN AMERICA
20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
20.3 LATIN AMERICA: COMPONENT SEGMENTATION (REVENUE)
20.4 LATIN AMERICA: APPLICATION SEGMENTATION (REVENUE)
20.5 LATIN AMERICA: END-USER SEGMENTATION (REVENUE)
20.6 LATIN AMERICA: KEY COUNTRIES
20.6.1 MEXICO: MARKET SIZE & FORECAST
20.6.2 ARGENTINA: MARKET SIZE & FORECAST
20.6.3 BRAZIL: MARKET SIZE & FORECAST
21 MIDDLE EAST & AFRICA
21.1 MARKET OVERVIEW
21.2 MARKET SIZE & FORECAST
21.3 MIDDLE EAST & AFRICA: COMPONENT SEGMENTATION (REVENUE)
21.4 MIDDLE EAST & AFRICA: APPLICATION SEGMENTATION (REVENUE)
21.5 MIDDLE EAST & AFRICA: END-USER SEGMENTATION (REVENUE)
21.6 MIDDLE EAST & AFRICA: KEY COUNTRIES
21.6.1 TURKEY: MARKET SIZE & FORECAST
21.6.2 SAUDI ARABIA: MARKET SIZE & FORECAST
21.6.3 SOUTH AFRICA: MARKET SIZE & FORECAST
22 COMPETITIVE LANDSCAPE
22.1 MARKET SHARE ANALYSIS
22.1.1 MEDTRONIC
22.1.2 PHILIPS HEALTHCARE
22.1.3 RESMED
22.2 MARKET SHARE ANALYSIS OVERVIEW BY SERVICES
22.2.1 WITHINGS
22.2.2 MEDM
22.2.3 IHEALTHUNIFIEDCARE
22.2.4 QARDIO
23 KEY VENDORS
23.1 MEDTRONIC
23.1.1 BUSINESS OVERVIEW
23.1.2 PRODUCT OFFERING
23.2 PHILIPS HEALTHCARE
23.2.1 BUSINESS OVERVIEW
23.2.2 PRODUCT OFFERING
23.3 RESMED
23.3.1 BUSINESS OVERVIEW
23.3.2 PRODUCT OFFERING
24 OTHER PROMINENT VENDORS
24.1 RESIDEO TECHNOLOGIES
24.1.1 BUSINESS OVERVIEW
24.1.2 PRODUCT OFFERING
24.2 HONEYWELL INTERNATIONAL
24.2.1 BUSINESS OVERVIEW
24.3 LIFESCIENCE TECHNOLOGIES
24.3.1 BUSINESS OVERVIEW
24.3.2 PRODUCT OFFERING
24.4 COFORGE
24.4.1 BUSINESS OVERVIEW
24.4.2 PRODUCT OFFERING
24.5 WITHINGS
24.5.1 BUSINESS OVERVIEW
24.5.2 PRODUCT OFFERING
24.6 MEDM
24.6.1 BUSINESS OVERVIEW
24.6.2 PRODUCT OFFERING
24.7 IHEALTHUNIFIEDCARE
24.7.1 BUSINESS OVERVIEW
24.7.2 PRODUCT OFFERINGS
24.8 QARDIO
24.8.1 BUSINESS OVERVIEW
24.8.2 PRODUCT OFFERINGS
24.9 100-PLUS
24.9.1 BUSINESS OVERVIEW
24.9.2 PRODUCT OFFERINGS
24.10 A&D COMPANY
24.10.1 BUSINESS OVERVIEW
24.10.2 PRODUCT OFFERINGS
24.11 ABBOTT
24.11.1 BUSINESS OVERVIEW
24.11.2 PRODUCT OFFERINGS
24.12 ALTUMVIEW SYSTEMS
24.12.1 BUSINESS OVERVIEW
24.12.2 PRODUCT OFFERINGS
24.13 BIOTRONIK
24.13.1 BUSINESS OVERVIEW
24.13.2 PRODUCT OFFERING
24.14 BOSTON SCIENTIFIC
24.14.1 BUSINESS OVERVIEW
24.14.2 PRODUCT OFFERINGS
24.15 BARDY DIAGNOSTICS
24.15.1 BUSINESS OVERVIEW
24.15.2 PRODUCT OFFERINGS
24.16 CARDIOMO CARE
24.16.1 BUSINESS OVERVIEW
24.16.2 PRODUCT OFFERINGS
24.17 CARDIOLOGS
24.17.1 BUSINESS OVERVIEW
24.17.2 PRODUCT OFFERINGS
24.18 DRAGERWERK AG
24.18.1 BUSINESS OVERVIEW
24.18.2 PRODUCT OFFERINGS
24.19 F. HOFFMANN-LA ROCHE
24.19.1 BUSINESS OVERVIEW
24.19.2 PRODUCT OFFERINGS
24.20 GE HEALTHCARE
24.20.1 BUSINESS OVERVIEW
24.20.2 PRODUCT OFFERINGS
24.21 GRANDCARE SYSTEMS
24.21.1 BUSINESS OVERVIEW
24.21.2 PRODUCT OFFERINGS
24.22 MASIMO CORPORATION
24.22.1 BUSINESS OVERVIEW
24.22.2 PRODUCT OFFERINGS
24.23 MEDOPAD
24.23.1 BUSINESS OVERVIEW
24.23.2 PRODUCT OFFERINGS
24.24 NIHON KOHDEN
24.24.1 BUSINESS OVERVIEW
24.24.2 PRODUCT OFFERINGS
24.25 OMRON HEALTHCARE
24.25.1 BUSINESS OVERVIEW
24.25.2 PRODUCT OFFERINGS
24.26 OSPLABS
24.26.1 BUSINESS OVERVIEW
24.26.2 PRODUCT OFFERINGS
24.27 SMITHS MEDICAL
24.27.1 BUSINESS OVERVIEW
24.27.2 PRODUCT OFFERINGS
24.28 SPACELABS HEALTHCARE
24.28.1 BUSINESS OVERVIEW
24.28.2 PRODUCT OFFERINGS
24.29 SENSEONICS
24.29.1 BUSINESS OVERVIEW
24.29.2 PRODUCT OFFERINGS
24.30 TELEMEDCARE
24.30.1 BUSINESS OVERVIEW
24.30.2 PRODUCT OFFERINGS
24.31 VITALCONNECT
24.31.1 BUSINESS OVERVIEW
24.31.2 PRODUCT OFFERINGS
24.32 VITLS
24.32.1 BUSINESS OVERVIEW
24.32.2 PRODUCT OFFERINGS
24.33 MODICARE
24.33.1 BUSINESS OVERVIEW
24.33.2 PRODUCT OFFERINGS
24.34 HILLROM
24.34.1 BUSINESS OVERVIEW
24.34.2 PRODUCT OFFERINGS
24.35 VIVIFY HEALTH
24.35.1 BUSINESS OVERVIEW
24.35.2 PRODUCT OFFERING
24.36 ACL DIGITAL
24.36.1 BUSINESS OVERVIEW
24.36.2 PRODUCT OFFERINGS
24.37 DEXCOM
24.37.1 BUSINESS OVERVIEW
24.37.2 PRODUCT OFFERING
24.38 IRHYTHM TECHNOLOGIES
24.38.1 BUSINESS OVERVIEW
24.38.2 PRODUCT OFFERING
24.39 VIVALINK
24.39.1 BUSINESS OVERVIEW
24.39.2 PRODUCT OFFERING
24.40 BIOBEAT
24.40.1 BUSINESS OVERVIEW
24.40.2 PRODUCT OFFERINGS
24.41 CAREVALIDATE
24.41.1 BUSINESS OVERVIEW
24.41.2 PRODUCT OFFERINGS
24.42 BIOFOURMIS
24.42.1 BUSINESS OVERVIEW
24.42.2 PRODUCT OFFERING
24.43 CAREMINDR
24.43.1 BUSINESS OVERVIEW
24.43.2 PRODUCT OFFERING
24.44 DATOS HEALTH
24.44.1 BUSINESS OVERVIEW
24.44.2 PRODUCT OFFERINGS
25 REPORT SUMMARY
25.1 KEY TAKEAWAYS
25.2 STRATEGIC RECOMMENDATIONS
26 QUANTITATIVE SUMMARY
26.1 MARKET BY GEOGRAPHY
26.2 MARKET BY COMPONENTS
26.2.1 MARKET BY DEVICES & SOFTWARE
26.2.2 MARKET BY CARDIAC MONITORING DEVICES
26.2.3 MARKET BY RESPIRATORY MONITORING DEVICES
26.3 MARKET BY APPLICATION
26.4 MARKET BY END-USER
26.5 NORTH AMERICA: BY COMPONENTS
26.5.1 DEVICES & SOFTWARE
26.5.2 CARDIAC MONITORING DEVICES
26.5.3 RESPIRATORY MONITORING DEVICES
26.6 NORTH AMERICA: BY APPLICATION
26.7 NORTH AMERICA: BY END-USER
26.8 EUROPE: BY COMPONENTS
26.8.1 DEVICES & SOFTWARE
26.8.2 CARDIAC MONITORING DEVICES
26.8.3 RESPIRATORY MONITORING DEVICES
26.9 EUROPE: BY APPLICATION
26.10 EUROPE: BY END-USER
26.11 APAC: BY COMPONENTS
26.11.1 DEVICES & SOFTWARE
26.11.2 CARDIAC MONITORING DEVICES
26.11.3 RESPIRATORY MONITORING DEVICES
26.12 APAC: BY APPLICATION
26.13 APAC: BY END-USER
26.14 LATIN AMERICA: BY COMPONENTS
26.14.1 DEVICES & SOFTWARE
26.14.2 CARDIAC MONITORING DEVICES
26.14.3 RESPIRATORY MONITORING DEVICES
26.15 LATIN AMERICA: BY APPLICATION
26.16 LATIN AMERICA: BY END-USER
26.17 MIDDLE EAST & AFRICA: BY COMPONENTS
26.17.1 DEVICES & SOFTWARE
26.17.2 CARDIAC MONITORING DEVICES
26.17.3 RESPIRATORY MONITORING DEVICES
26.18 MIDDLE EAST & AFRICA: BY APPLICATION
26.19 MIDDLE EAST & AFRICA: BY END-USER
27 APPENDIX
27.1 ABBREVIATIONS
LIST OF EXHIBITS
EXHIBIT 1 SEGMENTATION OF GLOBAL REMOTE PATIENT MONITORING MARKET
EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021
EXHIBIT 3 REMOTE PATIENT MONITORING SYSTEMS WORKING STRUCTURE
EXHIBIT 4 IMPACT OF INCREASING ROLE OF IOT IN REMOTE MONITORING & HEALTHCARE APPLICATIONS
EXHIBIT 5 WAYS HEALTHCARE IOT & REMOTE PATIENT MONITORING ARE TRANSFORMING CARE DELIVERY
EXHIBIT 6 IMPACT OF THE PARADIGM SHIFT TOWARD HOME-BASED HEALTHCARE DEVICES
EXHIBIT 7 IMPACT OF TELEMEDICINE USHERING NEW OPPORTUNITIES IN REMOTE MONITORING
EXHIBIT 8 IMPACT OF AGING POPULATION VULNERABLE TO CHRONIC DISEASES
EXHIBIT 9 IMPACT OF RISING WEARABLE MEDICAL TECHNOLOGY INNOVATIONS
EXHIBIT 10 IMPACT OF GROWING USE OF RPM TO PROACTIVELY MONITOR & IMPROVE PATIENT ENGAGEMENT
EXHIBIT 11 IMPACT OF INCREASING DEMAND FOR REMOTE MONITORING CAPABILITIES DUE TO COVID-19
EXHIBIT 12 IMPACT OF LOW AWARENESS OF REMOTE MONITORING IN DEVELOPING COUNTRIES
EXHIBIT 13 IMPACT OF LACK OF DATA ACCURACY
EXHIBIT 14 DATA QUALITY CHALLENGES DURING PGHD MANAGEMENT
EXHIBIT 15 GLOBAL REMOTE PATIENT MONITORING MARKET 2021–2027 ($ BILLION)
EXHIBIT 16 GLOBAL REMOTE PATIENT MONITORING MARKET BY COMPONENT
EXHIBIT 17 GLOBAL REMOTE PATIENT MONITORING MARKET BY DEVICES & SOFTWARE
EXHIBIT 18 GLOBAL REMOTE PATIENT MONITORING MARKET BY APPLICATION
EXHIBIT 19 GLOBAL REMOTE PATIENT MONITORING MARKET BY END-USER
EXHIBIT 20 GLOBAL REMOTE PATIENT MONITORING MARKET BY GEOGRAPHY
EXHIBIT 21 FIVE FORCES ANALYSIS 2021
EXHIBIT 22 INCREMENTAL GROWTH BY COMPONENT 2021 & 2027
EXHIBIT 23 INCREMENTAL GROWTH BY DEVICES & SOFTWARE 2021 & 2027
EXHIBIT 24 GLOBAL REMOTE PATIENT MONITORING MARKET BY DEVICES & SOFTWARE
EXHIBIT 25 GLOBAL REMOTE PATIENT MONITORING MARKET BY DEVICES & SOFTWARE: INCREMENTAL GROWTH
EXHIBIT 26 GLOBAL REMOTE PATIENT MONITORING MARKET BY DEVICES & SOFTWARE: ABSOLUTE GROWTH
EXHIBIT 27 GLOBAL REMOTE PATIENT MONITORING MARKET BY CARDIAC MONITORING DEVICES: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 28 GLOBAL REMOTE PATIENT MONITORING MARKET BY CARDIAC MONITORING DEVICES 2021–2027 ($ BILLION)
EXHIBIT 29 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027 ($ BILLION)
EXHIBIT 30 GLOBAL ECG REMOTE PATIENT MONITORING MARKET 2021–2027 ($ BILLION)
EXHIBIT 31 GLOBAL REMOTE PATIENT MONITORING MARKET BY CARDIAC MONITORS 2021–2027 ($ BILLION)
EXHIBIT 32 GLOBAL REMOTE BLOOD PRESSURE MONITORS MARKET 2021–2027 ($ BILLION)
EXHIBIT 33 GLOBAL REMOTE PATIENT MONITORING MARKET BY OTHER CARDIAC MONITORING DEVICES 2021–2027 ($ BILLION)
EXHIBIT 34 GLOBAL REMOTE PATIENT MONITORING MARKET BY RESPIRATORY MONITORING DEVICES: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 35 GLOBAL REMOTE PATIENT MONITORING MARKET BY RESPIRATORY MONITORING DEVICES 2021–2027 ($ BILLION)
EXHIBIT 36 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027 ($ BILLION)
EXHIBIT 37 GLOBAL REMOTE PATIENT MONITORING MARKET BY APNEA MONITORS 2021–2027 ($ BILLION)
EXHIBIT 38 GLOBAL REMOTE PATIENT MONITORING MARKET BY PULSE OXIMETERS 2021–2027 ($ BILLION)
EXHIBIT 39 GLOBAL REMOTE PATIENT MONITORING MARKET BY OTHER RESPIRATORY MONITORING DEVICES 2021–2027 ($ BILLION)
EXHIBIT 40 GLOBAL REMOTE PATIENT MONITORING MARKET BY BLOOD GLUCOSE MONITORS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 41 GLOBAL REMOTE PATIENT MONITORING MARKET BY BLOOD GLUCOSE MONITORS 2021–2027 ($ BILLION)
EXHIBIT 42 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027 ($ BILLION)
EXHIBIT 43 GLOBAL REMOTE FETAL & NEONATAL MONITORING DEVICES MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 44 GLOBAL REMOTE FETAL & NEONATAL MONITORING DEVICES MARKET 2021–2027 ($ BILLION)
EXHIBIT 45 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027 ($ BILLION)
EXHIBIT 46 GLOBAL REMOTE PATIENT MONITORING MARKET BY OTHER RPM DEVICES: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 47 GLOBAL REMOTE PATIENT MONITORING MARKET BY OTHER RPM DEVICES 2021–2027 ($ BILLION)
EXHIBIT 48 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027 ($ BILLION)
EXHIBIT 49 GLOBAL REMOTE PATIENT MONITORING MARKET BY SERVICES 2021–2027 ($ BILLION)
EXHIBIT 50 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027 ($ BILLION)
EXHIBIT 51 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
EXHIBIT 52 GLOBAL REMOTE PATIENT MONITORING MARKET BY APPLICATION
EXHIBIT 53 GLOBAL REMOTE PATIENT MONITORING MARKET BY APPLICATION: INCREMENTAL GROWTH
EXHIBIT 54 GLOBAL REMOTE PATIENT MONITORING MARKET BY APPLICATION: ABSOLUTE GROWTH
EXHIBIT 55 GLOBAL REMOTE CARDIOLOGY PATIENT MONITORING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 56 GLOBAL REMOTE CARDIOLOGY PATIENT MONITORING MARKET 2021–2027 ($ BILLION)
EXHIBIT 57 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027 ($ BILLION)
EXHIBIT 58 GLOBAL REMOTE PULMONOLOGY PATIENT MONITORING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 59 GLOBAL REMOTE PULMONOLOGY PATIENT MONITORING MARKET 2021–2027 ($ BILLION)
EXHIBIT 60 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027 ($ BILLION)
EXHIBIT 61 GLOBAL REMOTE ENDOCRINOLOGY PATIENT MONITORING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 62 GLOBAL REMOTE ENDOCRINOLOGY PATIENT MONITORING MARKET 2021–2027 ($ BILLION)
EXHIBIT 63 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027 ($ BILLION)
EXHIBIT 64 GLOBAL OTHER REMOTE PATIENT MONITORING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 65 GLOBAL OTHER REMOTE PATIENT MONITORING MARKET 2021–2027 ($ BILLION)
EXHIBIT 66 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027 ($ BILLION)
EXHIBIT 67 INCREMENTAL GROWTH BY END-USER 2021 & 2027
EXHIBIT 68 GLOBAL REMOTE PATIENT MONITORING MARKET BY END-USER
EXHIBIT 69 GLOBAL REMOTE PATIENT MONITORING MARKET BY END-USER: INCREMENTAL GROWTH
EXHIBIT 70 GLOBAL REMOTE PATIENT MONITORING MARKET BY HOSPITALS & SPECIALTY CLINICS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 71 GLOBAL REMOTE PATIENT MONITORING MARKET BY HOSPITALS & SPECIALTY CLINICS 2021–2027 ($ BILLION)
EXHIBIT 72 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027 ($ BILLION)
EXHIBIT 73 GLOBAL REMOTE PATIENT MONITORING MARKET BY HOMECARE SETTINGS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 74 GLOBAL REMOTE PATIENT MONITORING MARKET BY HOMECARE SETTINGS 2021–2027 ($ BILLION)
EXHIBIT 75 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027 ($ BILLION)
EXHIBIT 76 GLOBAL REMOTE PATIENT MONITORING MARKET BY AMBULATORY SURGICAL CENTERS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 77 GLOBAL REMOTE PATIENT MONITORING MARKET BY AMBULATORY SURGICAL CENTERS 2021–2027 ($ BILLION)
EXHIBIT 78 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027 ($ BILLION)
EXHIBIT 79 GLOBAL REMOTE PATIENT MONITORING MARKET BY LONG-TERM & ACUTE CARE CENTERS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 80 GLOBAL REMOTE PATIENT MONITORING MARKET BY LONG-TERM & ACUTE CARE CENTERS 2021–2027 ($ BILLION)
EXHIBIT 81 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027 ($ BILLION)
EXHIBIT 82 GLOBAL REMOTE PATIENT MONITORING MARKET BY OTHER END-USERS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 83 GLOBAL REMOTE PATIENT MONITORING MARKET BY OTHER END-USERS 2021–2027 ($ BILLION)
EXHIBIT 84 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027 ($ BILLION)
EXHIBIT 85 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 86 GLOBAL REMOTE PATIENT MONITORING MARKET BY GEOGRAPHY
EXHIBIT 87 GLOBAL REMOTE PATIENT MONITORING MARKET BY REGION: INCREMENTAL GROWTH
EXHIBIT 88 GLOBAL REMOTE PATIENT MONITORING MARKET BY REGION: ABSOLUTE GROWTH
EXHIBIT 89 NORTH AMERICA REMOTE PATIENT MONITORING MARKET: KEY COUNTRIES ($ BILLION)
EXHIBIT 90 NORTH AMERICA REMOTE PATIENT MONITORING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 91 NORTH AMERICA REMOTE PATIENT MONITORING MARKET 2021–2027 ($ BILLION)
EXHIBIT 92 INCREMENTAL GROWTH BY COMPONENT 2021 & 2027
EXHIBIT 93 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
EXHIBIT 94 INCREMENTAL GROWTH BY END-USER 2021 & 2027
EXHIBIT 95 INCREMENTAL GROWTH BY KEY COUNTRIES 2021 & 2027
EXHIBIT 96 REMOTE PATIENT MONITORING MARKET IN US. 2021–2027 ($ BILLION)
EXHIBIT 97 REMOTE PATIENT MONITORING MARKET IN CANADA 2021–2027 ($ BILLION)
EXHIBIT 98 EUROPE REMOTE PATIENT MONITORING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 99 EUROPE REMOTE PATIENT MONITORING MARKET: KEY COUNTRIES ($MILLION)
EXHIBIT 100 EUROPE REMOTE PATIENT MONITORING MARKET 2021–2027 ($ BILLION)
EXHIBIT 101 INCREMENTAL GROWTH BY COMPONENT 2021 & 2027
EXHIBIT 102 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
EXHIBIT 103 INCREMENTAL GROWTH BY END-USER 2021 & 2027
EXHIBIT 104 INCREMENTAL GROWTH BY EUROPE 2021 & 2027
EXHIBIT 105 REMOTE PATIENT MONITORING MARKET IN GERMANY 2021–2027 ($ BILLION)
EXHIBIT 106 REMOTE PATIENT MONITORING MARKET IN UK 2021–2027 ($ BILLION)
EXHIBIT 107 REMOTE PATIENT MONITORING MARKET IN FRANCE 2021–2027 ($ BILLION)
EXHIBIT 108 REMOTE PATIENT MONITORING MARKET IN SPAIN 2021–2027 ($ BILLION)
EXHIBIT 109 REMOTE PATIENT MONITORING MARKET IN ITALY 2021–2027 ($ BILLION)
EXHIBIT 110 APAC REMOTE PATIENT MONITORING MARKET: KEY COUNTRIES ($BILLION)
EXHIBIT 111 APAC REMOTE PATIENT MONITORING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 112 APAC REMOTE PATIENT MONITORING MARKET 2021–2027 ($ BILLION)
EXHIBIT 113 INCREMENTAL GROWTH BY COMPONENT 2021 & 2027
EXHIBIT 114 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
EXHIBIT 115 INCREMENTAL GROWTH BY END-USER 2021 & 2027
EXHIBIT 116 INCREMENTAL GROWTH BY APAC 2021 & 2027
EXHIBIT 117 REMOTE PATIENT MONITORING MARKET IN CHINA 2021–2027 ($ BILLION)
EXHIBIT 118 REMOTE PATIENT MONITORING MARKET IN JAPAN 2021–2027 ($ BILLION)
EXHIBIT 119 REMOTE PATIENT MONITORING MARKET IN INDIA 2021–2027 ($ BILLION)
EXHIBIT 120 DIGITAL HEALTH APPLICATIONS IN AUSTRALIA
EXHIBIT 121 REMOTE PATIENT MONITORING MARKET IN AUSTRALIA 2021–2027 ($ BILLION)
EXHIBIT 122 REMOTE PATIENT MONITORING MARKET IN SOUTH KOREA 2021–2027 ($ BILLION)
EXHIBIT 123 LATIN AMERICA REMOTE PATIENT MONITORING MARKET: KEY COUNTRIES ($ BILLION)
EXHIBIT 124 LATIN AMERICA REMOTE PATIENT MONITORING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 125 LATIN AMERICA REMOTE PATIENT MONITORING MARKET 2021–2027 ($ BILLION)
EXHIBIT 126 INCREMENTAL GROWTH BY COMPONENT 2021 & 2027
EXHIBIT 127 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
EXHIBIT 128 INCREMENTAL GROWTH BY END-USER 2021 & 2027
EXHIBIT 129 INCREMENTAL GROWTH BY LATIN AMERICA 2021 & 2027
EXHIBIT 130 REMOTE PATIENT MONITORING MARKET IN MEXICO 2021–2027 ($ BILLION)
EXHIBIT 131 REMOTE PATIENT MONITORING MARKET IN ARGENTINA 2021–2027 ($ BILLION)
EXHIBIT 132 REMOTE PATIENT MONITORING MARKET IN BRAZIL 2021–2027 ($ BILLION)
EXHIBIT 133 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING MARKET: KEY COUNTRIES ($ BILLION)
EXHIBIT 134 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 135 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING MARKET 2021–2027 ($ BILLION)
EXHIBIT 136 INCREMENTAL GROWTH BY COMPONENT 2021 & 2027
EXHIBIT 137 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
EXHIBIT 138 INCREMENTAL GROWTH BY END-USER 2021 & 2027
EXHIBIT 139 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2021 & 2027
EXHIBIT 140 REMOTE PATIENT MONITORING MARKET IN TURKEY 2021–2027 ($ BILLION)
EXHIBIT 141 REMOTE PATIENT MONITORING MARKET IN SAUDI ARABIA 2021–2027 ($ BILLION)
EXHIBIT 142 REMOTE PATIENT MONITORING MARKET IN SOUTH AFRICA 2021–2027 ($ BILLION)
EXHIBIT 143 MEDTRONIC REVENUE 2018-2021 ($ BILLION)
EXHIBIT 144 MEDTRONIC SEGMENT 2021 (%)
EXHIBIT 145 PHILIPS HEALTHCARE SEGMENT 2021 (%)
EXHIBIT 146 PHILIPS HEALTHCARE REVENUE 2018–2021 ($ BILLION)
EXHIBIT 147 PHILIPS HEALTHCARE REGIONAL REVENUE 2021 (%)
EXHIBIT 148 RESMED SEGMENT 2021 (%)
EXHIBIT 149 RESMED REVENUE 2018–2021 ($ BILLION)
LIST OF TABLES
TABLE 1 KEY CAVEATS
TABLE 2 CURRENCY CONVERSION 2015−2021
TABLE 3 COMPANIES OFFERING DIFFERENT TYPES OF RPM SYSTEMS
TABLE 4 INTERNET USERS IN LATIN AMERICA
TABLE 5 TOP REMOTE PATIENT MONITORING SOFTWARE IN BRAZIL 2022
TABLE 6 TELEMEDICINE SITES IN SOUTH AFRICA & APPLICATIONS
TABLE 7 MEDTRONIC: MAJOR PRODUCT OFFERINGS
TABLE 8 COVIDIEN PLC.: MAJOR PRODUCT OFFERINGS
TABLE 9 PHILIPS HEALTHCARE: MAJOR PRODUCT OFFERINGS
TABLE 10 RESMED: MAJOR PRODUCT OFFERINGS
TABLE 11 RESIDEO TECHNOLOGIES: MAJOR PRODUCT OFFERINGS
TABLE 12 HONEYWELL INTERNATIONAL: MAJOR PRODUCT OFFERINGS
TABLE 13 LIFESCIENCE TECHNOLOGIES: MAJOR PRODUCT OFFERINGS
TABLE 14 COFORGE: MAJOR PRODUCT OFFERINGS
TABLE 15 WITHINGS: MAJOR PRODUCT OFFERINGS
TABLE 16 MEDM: MAJOR PRODUCT OFFERINGS
TABLE 17 IHEALTHUNIFIEDCARE: MAJOR PRODUCT OFFERINGS
TABLE 18 QARDIO: MAJOR PRODUCT OFFERINGS
TABLE 19 100-PLUS: MAJOR PRODUCT OFFERINGS
TABLE 20 A&D COMPANY: MAJOR PRODUCT OFFERINGS
TABLE 21 ABBOTT: MAJOR PRODUCT OFFERINGS
TABLE 22 ALTUMVIEW SYSTEMS: MAJOR PRODUCT OFFERINGS
TABLE 23 BIOTRONIK: MAJOR PRODUCT OFFERINGS
TABLE 24 BOSTON SCIENTIFIC: MAJOR PRODUCT OFFERINGS
TABLE 25 BARDY DIAGNOSTICS: MAJOR PRODUCT OFFERINGS
TABLE 26 CARDIOMO CARE: MAJOR PRODUCT OFFERINGS
TABLE 27 CARDIOLOGS: MAJOR PRODUCT OFFERINGS
TABLE 28 DRAGERWERK AG: MAJOR PRODUCT OFFERINGS
TABLE 29 F. HOFFMANN-LA ROCHE.: MAJOR PRODUCT OFFERINGS
TABLE 30 ROCHE DIABETES CARE. MAJOR PRODUCT OFFERINGS
TABLE 31 GE HEALTHCARE: MAJOR PRODUCT OFFERINGS
TABLE 32 GRANDCARE SYSTEMS: MAJOR PRODUCT OFFERINGS
TABLE 33 MASIMO CORPORATION: MAJOR PRODUCT OFFERINGS
TABLE 34 MEDOPAD.: MAJOR PRODUCT OFFERINGS
TABLE 35 NIHON KOHDEN: MAJOR PRODUCT OFFERINGS
TABLE 36 OMRON HEALTHCARE: MAJOR PRODUCT OFFERINGS
TABLE 37 OSPLABS: MAJOR PRODUCT OFFERINGS
TABLE 38 SMITHS MEDICAL: MAJOR PRODUCT OFFERINGS
TABLE 39 SPACELABS HEALTHCARE: MAJOR PRODUCT OFFERINGS
TABLE 40 SENSEONICS: MAJOR PRODUCT OFFERINGS
TABLE 41 TELEMEDCARE: MAJOR PRODUCT OFFERINGS
TABLE 42 VITALCONNECT: MAJOR PRODUCT OFFERINGS
TABLE 43 VITLS: MAJOR PRODUCT OFFERINGS
TABLE 44 MODICARE: MAJOR PRODUCT OFFERINGS
TABLE 45 WELCH ALLYN: MAJOR PRODUCT OFFERINGS
TABLE 46 VIVIFY HEALTH: MAJOR PRODUCT OFFERINGS
TABLE 47 ACL DIGITAL: MAJOR PRODUCT OFFERINGS
TABLE 48 DEXCOM: MAJOR PRODUCT OFFERINGS
TABLE 49 IRHYTHM TECHNOLOGIES: MAJOR PRODUCT OFFERINGS
TABLE 50 VIVALINK: MAJOR PRODUCT OFFERINGS
TABLE 51 BIOBEAT: MAJOR PRODUCT OFFERINGS
TABLE 52 CAREVALIDATE: MAJOR PRODUCT OFFERINGS
TABLE 53 BIOFOURMIS: MAJOR PRODUCT OFFERINGS
TABLE 54 CAREMINDR: MAJOR PRODUCT OFFERINGS
TABLE 55 DATOS HEALTH: MAJOR PRODUCT OFFERINGS
TABLE 56 GLOBAL REMOTE PATIENT MONITORING MARKET BY GEOGRAPHY 2021–2027 ($ BILLION)
TABLE 57 GLOBAL REMOTE PATIENT MONITORING MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 58 GLOBAL REMOTE PATIENT MONITORING MARKET BY COMPONENT 2021−2027 ($ BILLION)
TABLE 59 GLOBAL REMOTE PATIENT MONITORING MARKET BY DEVICES & SOFTWARE 2021−2027 ($ BILLION)
TABLE 60 GLOBAL REMOTE PATIENT MONITORING MARKET BY CARDIAC MONITORING DEVICES 2021−2027 ($ BILLION)
TABLE 61 GLOBAL REMOTE PATIENT MONITORING MARKET BY RESPIRATORY MONITORING DEVICES 2021−2027 ($ BILLION)
TABLE 62 GLOBAL REMOTE PATIENT MONITORING MARKET BY APPLICATION 2021–2027 ($ BILLION)
TABLE 63 GLOBAL REMOTE PATIENT MONITORING MARKET BY END-USER 2021−2027 ($ BILLION)
TABLE 64 NORTH AMERICA REMOTE PATIENT MONITORING MARKET BY COMPONENT 2021−2027 ($ BILLION)
TABLE 65 NORTH AMERICA REMOTE PATIENT MONITORING MARKET BY DEVICES & SOFTWARE 2021−2027 ($ BILLION)
TABLE 66 NORTH AMERICA REMOTE PATIENT MONITORING MARKET BY CARDIAC MONITORING DEVICES 2021−2027 ($ BILLION)
TABLE 67 NORTH AMERICA REMOTE PATIENT MONITORING MARKET BY RESPIRATORY MONITORING DEVICES 2021−2027 ($ BILLION)
TABLE 68 NORTH AMERICA REMOTE PATIENT MONITORING MARKET BY APPLICATION 2021−2027 ($ BILLION)
TABLE 69 NORTH AMERICA REMOTE PATIENT MONITORING MARKET BY END-USER 2021–2027 ($ BILLION)
TABLE 70 EUROPE REMOTE PATIENT MONITORING MARKET BY COMPONENT 2021−2027 ($ BILLION)
TABLE 71 EUROPE REMOTE PATIENT MONITORING MARKET BY DEVICES & SOFTWARE 2021−2027 ($ BILLION)
TABLE 72 EUROPE REMOTE PATIENT MONITORING MARKET BY CARDIAC MONITORING DEVICES 2021−2027 ($ BILLION)
TABLE 73 EUROPE REMOTE PATIENT MONITORING MARKET BY RESPIRATORY MONITORING DEVICES 2021−2027 ($ BILLION)
TABLE 74 EUROPE REMOTE PATIENT MONITORING MARKET BY APPLICATION 2021−2027 ($ BILLION)
TABLE 75 EUROPE REMOTE PATIENT MONITORING MARKET BY END-USER 2021−2027 ($ BILLION)
TABLE 76 APAC REMOTE PATIENT MONITORING MARKET BY COMPONENTS 2021−2027 ($ BILLION)
TABLE 77 APAC REMOTE PATIENT MONITORING MARKET BY DEVICES & SOFTWARE 2021−2027 ($ BILLION)
TABLE 78 APAC REMOTE PATIENT MONITORING MARKET BY CARDIAC MONITORING DEVICES 2021−2027 ($ BILLION)
TABLE 79 APAC REMOTE PATIENT MONITORING MARKET BY RESPIRATORY MONITORING DEVICES 2021−2027 ($ BILLION)
TABLE 80 APAC REMOTE PATIENT MONITORING MARKET BY APPLICATION 2021−2027 ($ BILLION)
TABLE 81 APAC REMOTE PATIENT MONITORING MARKET BY END-USER 2021−2027 ($ BILLION)
TABLE 82 LATIN AMERICA REMOTE PATIENT MONITORING MARKET BY COMPONENT 2021−2027 ($ BILLION)
TABLE 83 LATIN AMERICA REMOTE PATIENT MONITORING MARKET BY DEVICES & SOFTWARE 2021−2027 ($ BILLION)
TABLE 84 LATIN AMERICA REMOTE PATIENT MONITORING MARKET BY CARDIAC MONITORING DEVICES 2021−2027 ($ BILLION)
TABLE 85 LATIN AMERICA REMOTE PATIENT MONITORING MARKET BY RESPIRATORY MONITORING DEVICES 2021−2027 ($ BILLION)
TABLE 86 LATIN AMERICA REMOTE PATIENT MONITORING MARKET BY APPLICATION 2021−2027 ($ BILLION)
TABLE 87 LATIN AMERICA REMOTE PATIENT MONITORING MARKET BY END-USER 2021−2027 ($ BILLION)
TABLE 88 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING MARKET BY COMPONENT 2021−2027 ($ BILLION)
TABLE 89 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING MARKET BY DEVICES & SOFTWARE 2021−2027 ($ BILLION)
TABLE 90 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING MARKET BY CARDIAC MONITORING DEVICES 2021−2027 ($ BILLION)
TABLE 91 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING MARKET BY RESPIRATORY MONITORING DEVICES 2021−2027 ($ BILLION)
TABLE 92 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING MARKET BY APPLICATION 2021−2027 ($ BILLION)
TABLE 93 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING MARKET BY END-USER 2021–2027 ($ BILLION)
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
